Table 3 De novo variants of chromatin modifier genes identified from the two CHD cohorts.

From: De novo damaging variants associated with congenital heart diseases contribute to the connectome

Variant Category

DDD Plus Study-Sifrim 2016 (N = 1039)

PCGC-Jin 2017 (N = 2645)

Combined CHD (N = 3684)

Controls (N = 1789)

Allele Count

OR

95% CI

p-value

Allele Count

OR

95% CI

p-value

Allele Count

OR

95% CI

p-value

Allele Count

Total

32

3.28

2.79, 6.01

7.15E-05

49

1.89

1.07, 3.33

0.028

81

2.27

1.32, 3.89

0.0017

16

PT

19

15.53

3.61, 66.8

9.53E-07

25

7.71

1.82, 32.6

5.10E-04

44

9.85

2.38, 40.7

1.55E-05

2

Missense

12

1.94

0.84, 4.51

0.13

17

1.04

0.47, 2.28

1.0

29

1.29

0.63, 2.65

0.60

10

D-mis

8

2.59

0.84, 7.92

0.094

8

0.98

0.32, 3.00

1.0

16

1.42

0.52, 3.88

0.64

5

PT or D-mis

27

6.33

2.75, 14.6

1.13E-06

33

2.91

1.28, 6.58

8.04E-03

60

3.84

1.75, 8.42

1.44E-04

7

Non D-mis

4

1.29

0.34, 4.81

0.74

9

1.10

0.37, 3.29

1.0

13

1.15

0.41, 3.24

1.0

5

SYN

0

0.18

0.01, 3.32

0.30

7

1.07

0.31, 3.66

1.0

7

0.77

0.23, 2.65

0.74

4